ARCHIVES

NCI Advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 15 No. 13 | March 31, 1989

Download PDF Visit The Full Archive

Related Articles

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

FDA Approves Rituxan For CLL

February 19, 2010

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008